Modulation of MUC1-dependent antiestrogen resistance

Details for Australian Patent Application No. 2006249801 (hide)

Owner Dana-Farber Cancer Institute, Inc.

Inventors Kufe, Donald W.

Agent Pizzeys

Pub. Number AU-A-2006249801

PCT Pub. Number WO2006/127972

Priority 60/685,052 26.05.05 US

Filing date 26 May 2006

Wipo publication date 30 November 2006

International Classifications

G01N 33/574 (2006.01) Investigating or analysing materials by specific methods not covered by groups - for cancer

Event Publications

31 January 2008 PCT application entered the National Phase

  PCT publication WO2006/127972 Priority application(s): WO2006/127972

19 November 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006249807-Compositions and methods for the treatment of cancer

2006249799-Electrothermal intervertebral disc treatment